Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Benefits, challenges, and strategies related to using presumptive recommendations for HPV vaccination: A qualitative study with rural and non-rural-serving primary care professionalsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2347018-2347018 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2347018 ;PMID: 38708779Full text available |
|
2 |
Material Type: Article
|
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2334084-2334084 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2334084 ;PMID: 38563792Full text available |
|
3 |
Material Type: Article
|
Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2337157-2337157 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2337157 ;PMID: 38644633Full text available |
|
4 |
Material Type: Article
|
Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional studyGlobal health action, 2024-12, Vol.17 (1), p.2325728-2325728 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2325728 ;PMID: 38596846Full text available |
|
5 |
Material Type: Article
|
Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemicHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2338953-2338953 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2338953 ;PMID: 38658178Full text available |
|
6 |
Material Type: Article
|
COVID-19 clinical trial participation and awareness in TexasHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2340692-2340692 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2340692 ;PMID: 38658140Full text available |
|
7 |
Material Type: Article
|
Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2343552-2343552 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2343552 ;PMID: 38723789Full text available |
|
8 |
Material Type: Article
|
Herpes zoster in older adults: Impact on carbon footprint in the United StatesHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2335722-2335722 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2335722 ;PMID: 38698759Full text available |
|
9 |
Material Type: Article
|
Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patientsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2343544-2343544 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2343544 ;PMID: 38655676Full text available |
|
10 |
Material Type: Article
|
Care-seeking patterns and timely access to care among survivors of sexual violence in North Kivu, the Democratic Republic of the Congo: a retrospective file-based studyGlobal Health Action, 2024-12, Vol.17 (1), p.2336708-2336708 [Peer Reviewed Journal]ISSN: 1654-9880 ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2336708 ;PMID: 38660982Full text available |
|
11 |
Material Type: Article
|
Estimation of cause-specific mortality in Rakai, Uganda, using verbal autopsy 1999-2019Global health action, 2024-12, Vol.17 (1), p.2338635-2338635 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2338635 ;PMID: 38717826Full text available |
|
12 |
Material Type: Article
|
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccinationHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2321672-2321672 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2321672 ;PMID: 38439670Full text available |
|
13 |
Material Type: Article
|
Dynamics of SARS-CoV-2 antibodies after natural infection: insights from a study on Pasteur Institute of Tunis employeesLibyan journal of medicine, 2024-12, Vol.19 (1), p.2348233-2348233 [Peer Reviewed Journal]ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2348233 ;PMID: 38693671Full text available |
|
14 |
Material Type: Article
|
SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinomaHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350101-2350101 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350101 ;PMID: 38738709Full text available |
|
15 |
Material Type: Article
|
Prevalence of multi-drug resistant bacteria in intensive care units at Tripoli University Hospital, Tripoli, LibyaLibyan journal of medicine, 2024-12, Vol.19 (1), p.2348235-2348235 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2348235 ;PMID: 38718270Full text available |
|
16 |
Material Type: Article
|
Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysisHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341454-2341454 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2341454 ;PMID: 38695296Full text available |
|
17 |
Material Type: Article
|
Association between friends' hesitancy and personal COVID-19 vaccine hesitancy among Chinese medical staffHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344290-2344290 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2344290 ;PMID: 38682698Full text available |
|
18 |
Material Type: Article
|
Acute diverticulitis with extraluminal air: is conservative treatment sufficient? A single-center retrospective studyTechniques in coloproctology, 2024-12, Vol.28 (1), p.50-50 [Peer Reviewed Journal]Springer Nature Switzerland AG 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. Springer Nature Switzerland AG. ;ISSN: 1123-6337 ;EISSN: 1128-045X ;DOI: 10.1007/s10151-024-02928-0 ;PMID: 38661970Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
The evaluation of goal-directed activities to promote well-being and health in heart failure: EUROIA scaleJournal of patient-reported outcomes, 2024-12, Vol.8 (1), p.47-47 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2509-8020 ;DOI: 10.1186/s41687-024-00723-x ;PMID: 38683439Full text available |
|
20 |
Material Type: Article
|
Predominance of MGMT promoter methylation among Pakistani glioblastoma patientsMolecular biology reports, 2024-12, Vol.51 (1), p.433-433 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. The Author(s), under exclusive licence to Springer Nature B.V. ;ISSN: 0301-4851 ;EISSN: 1573-4978 ;DOI: 10.1007/s11033-024-09363-2 ;PMID: 38520591Digital Resources/Online E-Resources |